Circulating Liquid Biopsy Biomarkers in Glioblastoma: Advances and Challenges
International Journal of Molecular Sciences,
Journal Year:
2024,
Volume and Issue:
25(14), P. 7974 - 7974
Published: July 21, 2024
Gliomas,
particularly
glioblastoma
(GBM),
represent
the
most
prevalent
and
aggressive
tumors
of
central
nervous
system
(CNS).
Despite
recent
treatment
advancements,
patient
survival
rates
remain
low.
The
diagnosis
GBM
traditionally
relies
on
neuroimaging
methods
such
as
magnetic
resonance
imaging
(MRI)
or
computed
tomography
(CT)
scans
postoperative
confirmation
via
histopathological
molecular
analysis.
Imaging
techniques
struggle
to
differentiate
between
tumor
progression
treatment-related
changes,
leading
potential
misinterpretation
delays.
Similarly,
tissue
biopsies,
while
informative,
are
invasive
not
suitable
for
monitoring
ongoing
treatments.
These
challenges
have
led
emergence
liquid
biopsy,
through
blood
samples,
a
promising
alternative
monitoring.
Presently,
cerebrospinal
fluid
(CSF)
sampling
offers
minimally
means
obtaining
tumor-related
information
guide
therapy.
idea
that
any
biofluid
tests
can
be
used
screen
many
cancer
types
has
huge
potential.
Tumors
release
various
components
into
bloodstream
other
biofluids,
including
cell-free
nucleic
acids
microRNAs
(miRNAs),
circulating
DNA
(ctDNA),
cells
(CTCs),
proteins,
extracellular
vesicles
(EVs)
exosomes,
metabolites,
factors.
factors
been
shown
cross
blood-brain
barrier
(BBB),
presenting
an
opportunity
well
real-time
assessment
distinct
genetic,
epigenetic,
transcriptomic,
proteomic,
metabolomic
changes
associated
with
brain
tumors.
their
potential,
clinical
utility
biopsy-based
biomarkers
is
somewhat
constrained
by
limitations
absence
standardized
methodologies
CSF
collection,
analyte
extraction,
analysis
methods,
small
cohort
sizes.
Additionally,
biopsies
offer
more
precise
insights
morphology
microenvironment.
Therefore,
objective
biopsy
should
complement
enhance
diagnostic
accuracy
patients
providing
additional
alongside
traditional
biopsies.
Moreover,
utilizing
combination
diverse
biomarker
may
effectiveness
compared
solely
relying
one
category,
potentially
improving
sensitivity
specificity
addressing
some
existing
GBM.
This
review
presents
overview
latest
research
found
in
discusses
diagnostic,
predictive,
prognostic
indicators,
future
perspectives.
Language: Английский
Identifying Novel Drug Targets for Calcific Aortic Valve Disease through Mendelian Randomization
D. Xu,
No information about this author
Jin Lü,
No information about this author
Yanfang Yang
No information about this author
et al.
Atherosclerosis,
Journal Year:
2025,
Volume and Issue:
unknown, P. 119110 - 119110
Published: Jan. 1, 2025
Language: Английский
Genome-wide pleiotropy analysis reveals shared architecture between renal traits and gastrointestinal tract diseases
Research Square (Research Square),
Journal Year:
2025,
Volume and Issue:
unknown
Published: Jan. 30, 2025
Abstract
Background:
Comorbidities
between
gastrointestinal
tract
(GIT)
and
renal
diseases
have
been
widely
reported,
but
the
shared
genetic
architecture
of
gut
traits
remains
unclear.
Objective:
To
investigate
etiology
causal
relationships
or
involved
in
gut-renal
axis.
Methods:
We
explored
global
local
correlations,
pleiotropic
effects
at
variants
gene
levels,
associations
pair-wise
GIT
diseases,
as
well
potential
target
drugs
by
using
latest
large-scale
genome-wide
association
study
(GWAS)
summary
data
five
(BUN,
eGFR,
CKD,
IgAN,
KSD)
four
(PUD,
GORD,
IBD,
IBS).
Results:
Renal
were
genetically
correlated
globally
locally
across
eight
20
trait
pairs
(BUN-GORD,
BUN-IBD,
BUN-IBS,
CKD-IBD,
IgAN-IBD,
KSD-PUD,
KSD-GORD,
KSD-IBS).
Pleiotropic
analysis
identified
222
loci
prioritized
169
genes
for
pairs,
including
21
novel
that
not
significant
original
GWASs,
colocalized
loci,
29
drug-targeting
genes.
Among
rs3129861
HLA-DRA
was
potentially
BUN-GORD
(PP4
=
0.814).
KIF5B
is
a
eGFR-IBD
CKD-IBD
rs12572072
0.929)
rs61844306
0.898),
both
which
are
eQTLs
expressed
cultured
fibroblasts
cells.
CKD
IBD
also
PVALEF
with
PP4
0.800
rs138610699.
In
addition,
rs6873866
casual
variant
ERAP2
IgAN
with
PP4=0.800,
rs6873866-C
allele
negatively
associated
expression
multiple
tissues.
Furthermore,
tissue
cell-type
specific
enrichment
found
over-expressed
kidney
cortex,
immune-related
tissues
cell
types.
Mendelian
randomization
revealed
nominal
observed
on
IBS,
PUD
GORD
eGFR.
Conclusion:
These
findings
suggested
highlighted
analyses
drug
repurposing
comorbidities
Language: Английский
Coding and regulatory somatic profiling of triple-negative breast cancer in Sub-Saharan African patients
Ricardo Pinto,
No information about this author
Dylan Ferreira,
No information about this author
P. Salamanca
No information about this author
et al.
Scientific Reports,
Journal Year:
2025,
Volume and Issue:
15(1)
Published: March 25, 2025
The
burden
of
triple-negative
breast
cancer
(TNBC)
may
be
shaped
by
genetic
factors,
particularly
inherited
and
somatic
mutation
profiles.
However,
data
on
this
topic
remain
limited,
especially
for
the
African
continent,
where
a
higher
TNBC
incidence
is
observed.
In
age
precision
medicine,
cataloguing
diversity
in
patients
becomes
imperative.
We
performed
whole
exome
sequencing,
including
untranslated
regions,
30
samples
from
Angola
Cape
Verde,
which
allowed
to
ascertain
potential
regulatory
mutations
first
time.
A
high
was
observed
cohort,
with
86%
variants
being
so
far
unreported.
Recurring
predictive
functional
algorithms,
17%
single
nucleotide
were
predicted
deleterious
at
protein
level,
20%
overlapped
candidate
cis-regulatory
elements
controlling
gene
expression.
Several
these
functionally-impactful
copy
number
variation
(mainly
1q,
8q,
6
10p)
occur
known
BC-
all
cancer-driver
genes,
enriched
several
mechanisms,
response
radiation
related
DNA
repair
mechanisms.
TP53
top
BC-driver
but
our
results
identified
possible
novel
driver
genes
that
play
main
role
context,
as
TTN,
CEACAM7,
DEFB132,
COPZ2
GAS1.
These
findings
emphasize
need
expand
omics
screenings
across
region
globe
highest
genomic
diversity,
accelerating
discovery
new
cancer-related
pathways.
Language: Английский
The role of polysaccharides in immune regulation through gut microbiota: mechanisms and implications
Frontiers in Immunology,
Journal Year:
2025,
Volume and Issue:
16
Published: March 31, 2025
Polysaccharides,
as
complex
carbohydrates,
play
a
pivotal
role
in
immune
modulation
and
interactions
with
the
gut
microbiota.
The
diverse
array
of
dietary
polysaccharides
influences
microbial
ecology,
impacting
responses,
metabolism,
overall
well-being.
Despite
their
recognized
benefits,
there
is
limited
understanding
precise
mechanisms
by
which
modulate
system
through
A
comprehensive
search
Web
Science,
PubMed,
Google
Scholar,
Embase
up
to
May
2024
was
conducted
identify
relevant
studies.
This
study
employs
systematic
approach
explore
interplay
between
microbiota,
focusing
on
cytokine-mediated
short-chain
fatty
acid
(SCFA)-mediated
pathways.
findings
underscore
significant
shaping
composition
function
thereby
influencing
regulation
metabolic
processes.
However,
further
research
necessary
elucidate
detailed
molecular
translate
these
into
clinical
applications.
Language: Английский
Genetic associations of plasma proteins and breast cancer identify potential therapeutic drug candidates
Liuliu Quan,
No information about this author
Xin Luo,
No information about this author
Chenxu Meng
No information about this author
et al.
Communications Biology,
Journal Year:
2025,
Volume and Issue:
8(1)
Published: April 15, 2025
Language: Английский
Identification of novel plasma proteins as promising noninvasive biomarker for early diagnosis and surveillance of pancreatic ductal adenocarcinoma
Journal of Gastroenterology,
Journal Year:
2025,
Volume and Issue:
unknown
Published: April 26, 2025
Language: Английский
Adiposity and cancer: meta-analysis, mechanisms, and future perspectives
medRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2024,
Volume and Issue:
unknown
Published: Feb. 18, 2024
Obesity
is
a
recognised
risk
factor
for
many
cancers
and
with
rising
global
prevalence,
has
become
leading
cause
of
cancer.
Here
we
summarise
the
current
evidence
from
both
population-based
epidemiologic
investigations
experimental
studies
on
role
obesity
in
cancer
development.
This
review
presents
new
meta-analysis
using
data
40
million
individuals
reports
positive
associations
19
types.
Utilising
major
East
Asia,
also
shows
that
strength
varies
regionally,
stronger
relative
risks
several
Asia.
mechanisms
linking
identifies
promising
future
research
directions.
These
include
use
imaging
to
circumvent
methodological
issues
involved
body
mass
index
omics
technologies
resolve
biologic
greater
precision
clarity.
Language: Английский
Shedding light on the role of complement C4 activation in cancer
Darin Cheung,
No information about this author
Mohammad Ali Hassan,
No information about this author
Trung-Hieu Huynh
No information about this author
et al.
Human Immunology,
Journal Year:
2024,
Volume and Issue:
86(1), P. 111226 - 111226
Published: Dec. 27, 2024
Language: Английский
Mendelian randomization study of the association between cathepsins and melanoma
World Academy of Sciences Journal,
Journal Year:
2024,
Volume and Issue:
6(5)
Published: July 3, 2024
Malignant
melanoma
is
a
skin
tumor
with
poor
prognosis.
Therefore,
it
critical
to
explore
the
risk
factors
associated
outcome
of
this
tumor.
In
present
study,
Mendelian
randomization
(MR)
was
used
investigate
causal
association
between
cathepsins
and
malignant
melanoma.
Summary
statistical
data
on
five
from
European
participants
were
extracted
as
exposure
data.
Data
genome‑wide
study
ancestry
Single
nucleotide
polymorphisms
instrumental
variables
(IVs).
including
3,751
cases
372,016
controls,
MR
analysis
conducted
examine
effects
these
IVs
The
inverse
variance‑weighted
method
for
analysis.
addition,
MR‑Egger,
weighted
median
pleiotropy
residual
sum
complementary
analyses.
Furthermore,
series
sensitivity
analyses
performed
ensure
validity
robustness
results.
gene‑predicted
results
indicated
no
(P>0.05).
Cathepsin
S
[odds
ratio
(OR),
1.000;
95%
confidence
interval
(CI),
0.999‑1.001;
P=0.943],
cathepsin
B
(OR,
CI,
P=0.763),
O
P=0.646),
E
0.999;
0.998‑1.001;
P=0.375)
L2
1.101;
0.831‑1.458;
P=0.503)
not
significantly
developing
Sensitivity
demonstrated
significant
bias
in
aforementioned
On
whole,
did
provide
evidence
that
(cathepsin
S,
B,
O,
L2)
are
causally
related
Language: Английский